Abstract:Activation of Wnt/β‐catenin signalling is frequently observed in many types of cancer including hepatocellular carcinoma (HCC). We recently reported that cullin 4B (CUL4B), a scaffold protein that assembles CRL4B ubiquitin ligase complexes, is overexpressed in many types of solid tumours and contributes to epigenetic silencing of tumour suppressors. In this study, we characterized the function of CUL4B in HCC and investigated whether CUL4B is involved in the regulation of Wnt/β‐catenin signalling. CUL4B and β‐catenin were frequently up‐regulated and positively correlated in HCC tissues. CUL4B activated Wnt/β‐catenin signalling by protecting β‐catenin from GSK3‐mediated degradation, achieved through CUL4B‐mediated epigenetic silencing of Wnt pathway antagonists. Knockdown of CUL4B resulted in the up‐regulation of Wnt signal antagonists such as DKK1 and PPP2R2B. Simultaneous knockdown of PPP2R2B partially reversed the down‐regulation of β‐catenin signalling caused by CUL4B depletion. Furthermore, CRL4B promoted the recruitment and/or retention of PRC2 at the promoters of Wnt antagonists and CUL4B knockdown decreased the retention of PRC2 components as well as H3K27me3. Knockdown of CUL4B reduced the proliferation, colony formation, and invasiveness of HCC cells in vitro and inhibited tumour growth in vivo, and these effects were attenuated by introduction of exogenous β‐catenin or simultaneous knockdown of PPP2R2B. Conversely, ectopic expression of CUL4B enhanced the proliferation and invasiveness of HCC cells. We conclude that CUL4B can up‐regulate Wnt/β‐catenin signalling in human HCC through transcriptionally repressing Wnt antagonists and thus contributes to the malignancy of HCC. Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

CRL4B Interacts with and Coordinates the SIN3A-HDAC Complex to Repress CDKN1A and Drive Cell Cycle Progression

The Functions and Properties of Cullin-5, a Potential Therapeutic Target for Cancers.

CRL4B promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3A in DNA methylation-based epigenetic silencing

CRL4B promotes tumorigenesis by coordinating with SUV39H1|[sol]|HP1|[sol]|DNMT3A in DNA methylation-based epigenetic silencing

CRL4B catalyzes H2AK119 monoubiquitination and coordinates with PRC2 to promote tumorigenesis.

CUL4B promotes replication licensing by up-regulating the CDK2-CDC6 cascade.

Involvement of CUL4 ubiquitin E3 ligases in regulating CDK inhibitors Dacapo/p27(Kip1) and cyclin E degradation

Increased Cul1 Expression Promotes Melanoma Cell Proliferation Through Regulating P27 Expression

Pathogenic Roles of the Cullin E3 Ligase Scaffolding Protein CUL4B

SIRT7 deacetylates DDB1 and suppresses the activity of the CRL4 E3 ligase complexes.

CUL4 E3 ligase regulates the proliferation and apoptosis of lung squamous cell carcinoma and small cell lung carcinoma

CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway

X-linked Intellectual Disability Gene CUL4B Targets Jab1/CSN5 for Degradation and Regulates Bone Morphogenetic Protein Signaling.

Characterization of Nuclear Localization Signal in the N Terminus of CUL4B and Its Essential Role in Cyclin E Degradation and Cell Cycle Progression

CRL4B complex-mediated H2AK119 monoubiquitination restrains Th1 and Th2 cell differentiation

CRL4BDCAF11 E3 ligase targets p21 for degradation to control cell cycle progression in human osteosarcoma cells

CUL4B Activates Wnt/β‐catenin Signalling in Hepatocellular Carcinoma by Repressing Wnt Antagonists

CRL4 Antagonizes SCFFbxo7-mediated Turnover of Cereblon and BK Channel to Regulate Learning and Memory

CUL4B Regulates Autophagy Via JNK Signaling in Diffuse Large B-cell Lymphoma.

KDM2B/FBXL10 Targets C-Fos for Ubiquitylation and Degradation in Response to Mitogenic Stimulation

The HDAC-Associated Sin3B Protein Represses DREAM Complex Targets and Cooperates with APC/C to Promote Quiescence